Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Limb mass, Pharyngeal mass, SARS-CoV-2 test, Thyroid mass
Clinical narrative: lumps on foot +thyroid area; The lumps developed in throat area like I have double chin; Lump in left ankle area/lumps on foot; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 43-year-old female patient received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 24Sep2023 as dose 1, single (Lot number: HG4628) at the age of 42 years intramuscular, in right arm for covid-19 immunisation; for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (ongoing), notes: Years ago; "Eczema" (ongoing), notes: Years ago; "High BMI" (unspecified if ongoing), notes: High BMI; "Prediabetes" (ongoing), notes: Years ago; "High blood sugar" (ongoing); "High cholesterol" (ongoing), notes: Years ago; "Booster dose due to a weakened immune system" (unspecified if ongoing), notes: Booster dose due to a weakened immune system. Concomitant medication(s) included: METFORMIN taken for blood glucose abnormal (ongoing); INFLUENZA taken for influenza immunisation, start date: 12Sep2023, stop date: 12Sep2023. Vaccination history included: moderna covid-19 vaccine (Dose: 1, Time: afternoon, Anatomical site: right arm, Route of administration: Intramuscular, Batch/Lot number: 030L20A (Moderna)), administration date: 21Jan2021, when the patient was 40-year-old, for COVID-19 immunization; moderna covid-19 vaccine (Dose: 2, Time: afternoon, Anatomical site: left arm, Route of administration: Intramuscular, Batch/Lot number: 010MZ0A (Moderna)), administration date: 19Feb2021, when the patient was 40-year-old, for COVID-19 immunization; moderna covid-19 vaccine (Dose: 3, Time: afternoon, Anatomical site: right arm, Route of administration: Intramuscular, Batch/Lot number: 012F21A (Moderna) 1st booster), administration date: 11May2021, when the patient was 40-year-old, for COVID-19 immunization; bnt162b2;bnt162b2 omi ba.4-5 (Dose: 4, Time: afternoon, Anatomical site: right arm, Route of administration: Intramuscular, Batch/Lot number: GH9694), administration date: 14Sep2022, when the patient was 41-year-old, for COVID-19 immunization. The following information was reported: LIMB MASS (non-serious) with onset 2023, outcome "not recovered", described as "Lump in left ankle area/lumps on foot"; PHARYNGEAL MASS (non-serious) with onset 2023, outcome "not recovered", described as "The lumps developed in throat area like I have double chin"; THYROID MASS (medically significant) with onset 2023, outcome "not recovered", described as "lumps on foot +thyroid area". The events "lumps on foot +thyroid area", "the lumps developed in throat area like i have double chin" and "lump in left ankle area/lumps on foot" required physician office visit. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Negative, notes: Consistently tested negative for COVID throughout and before vaccination. Therapeutic measures were not taken as a result of thyroid mass.  Additional information: Booster dose due to a weakened immune system. Patient also had asthma, eczema, high BMI, Prediabetes, High cholesterol. Prior Vaccination was Flu shot of unknown Manufacturer on 12Sep2023 in left arm and there were no previous doses of it. Patient was taking Metformin for high blood sugar. The patient was consistently tested negative for COVID throughout and before vaccination. AE Term: lumps on foot and thyroid area. Seriousness criteria: Persistent/Significant disability/Incapacity Won't diminish scans said okay but still lumps remain. AE required visit to Physician Office. No treatment was received the events. Patient told that the lumps developed in throat area like she had double chin, lump in the left ankle area won't go down its been months.